Global TB Programme
Mario Raviglione, Director
Mario C. Raviglione was Director of the Global TB Programme at the World Health Organization (WHO) between 2003 and November 2017.
He joined WHO in 1991 to work on TB/HIV research and TB epidemiology in Europe. He contributed to the development of the DOTS strategy in 1994, and set up the global drug-resistance surveillance project (1994) and the global TB surveillance & monitoring system (1995). In his first decade at WHO, he also worked on experimental regimens for treatment of latent infection in the mouse model (early 1990s), described the feasibility of preventive therapy in Africa (1995), first reported the TB control crisis in Eastern Europe (1993), and co-developed estimates and projections of the global TB epidemic. Between 1999 and 2003, he was Coordinator for Strategy and Operations globally, taking charge particularly of surveillance and programme monitoring; operational research; TB/HIV and multi drug-resistant TB responses; and DOTS expansion worldwide.
Currently, as Director of the Global TB Programme of WHO, he is responsible for setting norms, policies and standards on global TB control, coordinating technical support, monitoring the global situation, and developing innovative interventions through translation of new evidence into policies & practice and through addressing system challenges such as community and private sector engagement. As part of this work, he developed the Stop TB Strategy in 2006. He has been a member of the Stop TB Partnership Coordinating Board since its establishment in 2001 and has worked in many countries world-wide. He has published over 250 articles and chapters on the topics of infectious diseases, HIV/AIDS and TB in the most influential health journals and books, including in the last five editions of the prestigious Harrison's Principles of Internal Medicine. He is among the top 10 most cited authors in the TB field. He is editor of the 3rd and 4th (2006, 2009) edition of "Tuberculosis - A comprehensive International Approach", a landmark multi-author book, and associate editor of other books.
As a leading expert in TB, he has served as a visiting professor at Johns Hopkins and Geneva Universities. He is professor at the medical schools of the University of Brescia and the University of Modena & Reggio Emilia in Italy. He has lectured at top international health conferences in about 50 countries world-wide. He sits in a variety of scientific committees. He has worked as WHO focal point on G8 global health issues in 2009 and on World Health Day 2011 devoted to combating antimicrobial resistance. He graduated from the University of Turin in Italy in 1980, and trained in internal medicine and infectious diseases in New York (where he was Chief Medical Resident at Cabrini's Medical Centre) and Boston, where he was appointed an AIDS Clinical Research Fellow at Beth Israel Hospital, Harvard Medical School. In 2005, he received the Princess Chichibu TB Global Award for his achievements in TB control. In 2009 he was nominated Fellow of the Royal Academy of Physicians (F.R.C.P., London, UK). In 2010 he received the Wolfheze 20 Year Jubilee Award for his contributions to modern TB control practices in Europe.